For this special issue of *Veterinary Microbiology* entitled "**Advances in Vaccine Research against Economically Important Viral Diseases of Food Animals"** we feel privileged in having been able to compile a distinguished list of authors that includes renowned specialists working in key viral diseases of poultry, swine and ruminants. Veterinary viral vaccinology has enjoyed a leadership role in advancing vaccine technologies, provided not only by the obvious advantage afforded by the possibility of testing fundamental immunization principles directly in target host animal species, but also because of the broader range of immunization strategies that our veterinary toolbox entails, including replicating and non-replicating immunization approaches, and various adjuvants approved for use in target species.

Historically a fundamental contribution of viral veterinary vaccines has been the improvement of both animal welfare and public health. Beyond these explicit contributions remains the central role that veterinary viral vaccines have in safeguarding food security for a world that, by the year 2030, is anticipated to need to feed more than 8 billion people. Given this background, we have selected, for three major food animal species, reviews that highlight the most emblematic viral vaccination successes and persisting challenges.

The reviews of viral diseases in poultry include Marek\'s disease, infectious bursal disease, Newcastle disease, and infectious bronchitis for which vaccination has been successful in preventing spread of disease. However, with the continuing evolution of the viruses and emergence of new variants and virulent strains, vaccines and vaccination regimens need to be constantly updated. For trade-sensitive diseases like influenza, in addition to preventing disease, it is important to differentiate the infected from vaccinated animals (DIVA). The reviews describe licensed vectored vaccines which can provide early protection through a cost-effective route of administration and are DIVA capable at the same time. The reviews also include reoviral arthritis and infectious laryngotracheitis, two diseases that are very challenging for vaccine development. Several new strategies to improve both live attenuated and viral vector vaccines are discussed.

In the swine species the topics covered include success stories such as Pseudorabies DIVA vaccines (a quintessential representation of the impact of biotechnology on veterinary vaccinology), the novel first live attenuated RNA virus vaccine endowed with DIVA capability (classical swine fever), and the control of porcine circovirus-2 infections by adequate non-replicating immunogens. Other examples include those which, while experiencing significant progress toward effective vaccination, still remain challenged by the great antigenic diversity of circulating strains (such are the cases of PRRSV and swine influenza virus) or by the strict refinement required to achieve successful mucosal lactogenic immunity (porcine epidemic diarrhea virus and other coronaviruses). Perhaps the most representative challenge for swine viral vaccines is the case of African swine fever virus, in which incipient but definitive progress is being made to control infection by immunization, now that the gravity and threat represented by this infectious disease has expanded to non-traditional, extended geographical areas.

For ruminants we have included reviews that highlight the challenge of balancing safety and efficacy when using vaccines to prevent fetal loss due to infection by bovine herpesvirus type 1 and bovine virus diarrhea virus, and that summarize the successes and ongoing frustrations for those who wish to protect ruminants against viruses with substantial genetic variation, such as foot-and-mouth diseases virus or bluetongue virus. The review on *peste des petites ruminants* virus (PPRV) illuminates the impact of societal factors on veterinary vaccinology; the current PPRV vaccine is effective but limited by the need for a cold chain which is not reliably available in many areas where this virus has serious impact. Researchers who develop an effective PPRV vaccine that is broadly effective and stable without refrigeration will have made a substantial contribution to both animal and human wellbeing. And as indicted in the bovine respiratory syncytial virus review, the history of bovine and human RSV vaccination was marked by episodes of vaccine enhanced disease. The safe and relatively effective bovine RSV vaccines that are currently available give veterinarians a useful tool that physicians still lack.

We believe this issue provides a valuable and unique contribution to the veterinary vaccine literature as related to food animal species. In closing, we extend our appreciation to all of the contributors for their outstanding work, and to Editor-in-Chief X.J. Meng and members of the Elsevier staff for their support in generating this special issue.
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